Two Copies of the Human Apolipoprotein C-I Gene Are Linked Closely to the Apolipoprotein E Gene
Overview
Affiliations
The gene for human apolipoprotein (apo) C-I was selected from human genomic cosmid and lambda libraries. Restriction endonuclease analysis showed that the gene for apoC-I is located 5.5 kilobases downstream of the gene for apoE. A copy of the apoC-I gene, apoC-I', is located 7.5 kilobases downstream of the apoC-I gene. Both genes contain four exons and three introns; the apoC-I gene is 4653 base pairs long, the apoC-I' gene 4387 base pairs. In each gene, the first intron is located 20 nucleotides upstream from the translation start signal; the second intron, within the codon of Gly-7 of the signal peptide region; and the third intron, within the codon for Arg39 of the mature plasma protein coding region. The upstream apoC-I gene encodes the known apoC-I plasma protein and differs from the downstream apoC-I' gene in about 9% of the exon nucleotide positions. The most important difference between the exons results in a change in the codon for Gln-2 of the signal peptide region, which introduces a translation stop signal in the downstream gene. Major sequence differences are found in the second and third introns of the apoC-I and apoC-I' genes, which contain 9 and 7.5 copies, respectively, of Alu family sequences. The apoC-I gene is expressed primarily in the liver, and it is activated when monocytes differentiate into macrophages. In contrast, no mRNA product of the apoC-I' gene can be detected in any tissue, suggesting that it may be a pseudogene. The similar structures and the proximity of the apoE and apoC-I genes suggest that they are derived from a common ancestor. Furthermore, they may be considered to be constituents of a family of seven apolipoprotein genes (apoE, -C-I, -C-II, -C-III, -A-I, -A-II, and -A-IV) that have a common evolutionary origin.
Coordinated single-cell tumor microenvironment dynamics reinforce pancreatic cancer subtype.
Oh K, Yoo Y, Torre-Healy L, Rao M, Fassler D, Wang P Nat Commun. 2023; 14(1):5226.
PMID: 37633924 PMC: 10460409. DOI: 10.1038/s41467-023-40895-6.
Rouland A, Masson D, Lagrost L, Verges B, Gautier T, Bouillet B Cardiovasc Diabetol. 2022; 21(1):272.
PMID: 36471375 PMC: 9724408. DOI: 10.1186/s12933-022-01703-5.
Nelson B, Daugherty C, Sharp R, Booth J, Patel V, Metcalf J Front Immunol. 2022; 13:1054477.
PMID: 36466930 PMC: 9709479. DOI: 10.3389/fimmu.2022.1054477.
Feasibility of ApoC1 serum levels as tumor biomarker in glioblastoma patients: a pilot study.
Hilbert M, Kuzman P, Mueller W, Meixensberger J, Nestler U Sci Rep. 2022; 12(1):16981.
PMID: 36216850 PMC: 9550816. DOI: 10.1038/s41598-022-21216-1.
Li W, Wang Y, Huang R, Lian F, Xu G, Wang W Mol Biol Rep. 2022; 49(10):9373-9378.
PMID: 35941416 DOI: 10.1007/s11033-022-07789-0.